PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15764716-6	2005	Hepatocytes that contain both dihydropyrimidinase and dihydroorotase completely hydrolyzed dexrazoxane to ADR-925 and released it into the extracellular medium.	Dexrazoxane	91-102	dihydropyrimidinase	Rattus norvegicus	30-49	
7900413-4	1994	4-Chlorobenzenesulphonamide</compound-id>, which is a strong inhibitor of dihydropyrimidine amidohydrolase (DHPase), caused 82% inhibition of the loss of dexrazoxane from the hepatocyte suspension.	Dexrazoxane	154-165	dihydropyrimidinase	Rattus norvegicus	74-106	
7900413-4	1994	4-Chlorobenzenesulphonamide</compound-id>, which is a strong inhibitor of dihydropyrimidine amidohydrolase (DHPase), caused 82% inhibition of the loss of dexrazoxane from the hepatocyte suspension.	Dexrazoxane	154-165	dihydropyrimidinase	Rattus norvegicus	108-114	
7900413-9	1994	The ratios of the rates at which each of the one-ring open intermediates of dexrazoxane and levrazoxane were produced in the hepatocyte suspension are also consistent with DHPase being primarily responsible for the metabolism of dexrazoxane and levrazoxane.	Dexrazoxane	76-87	dihydropyrimidinase	Rattus norvegicus	172-178	
7900413-9	1994	The ratios of the rates at which each of the one-ring open intermediates of dexrazoxane and levrazoxane were produced in the hepatocyte suspension are also consistent with DHPase being primarily responsible for the metabolism of dexrazoxane and levrazoxane.	Dexrazoxane	229-240	dihydropyrimidinase	Rattus norvegicus	172-178	
7900413-11	1994	Thus, the DHPase-catalysed formation of the one-ring opened intermediates enhances the rate at which the presumably active metal-ion binding forms of dexrazoxane are produced in the hepatocyte.	Dexrazoxane	150-161	dihydropyrimidinase	Rattus norvegicus	10-16